11. Income Taxes

The components of the provision (benefit) for income taxes were as follows for the years ended December 31, 2025 and 2024 (in thousands):

 

 

Years Ended December 31,

 

 

2025

 

 

2024

 

Current:

 

 

 

 

 

 

Federal

 

$

12

 

 

$

(7

)

State

 

 

 

 

 

 

Total current

 

 

12

 

 

 

(7

)

Deferred:

 

 

 

 

 

 

Federal

 

 

 

 

 

(491

)

State

 

 

 

 

 

 

Total deferred

 

 

 

 

 

(491

)

Provision (benefit) for income taxes

 

$

12

 

 

$

(498

)

 

As discussed in Note 2, we adopted ASU 2023-09 on a prospective basis beginning with the year ended December 31, 2025. For the year ended December 31, 2025, the tax provision expense was not material. For the year ended December 31, 2024, the Company recorded income tax benefit of $0.5 million.

A reconciliation of the Company’s effective tax rate to the statutory U.S. federal rate is as follows:

 

Year Ended December 31, 2025

 

Amount

 

 

Percentage

U.S. federal taxes at statutory rate

 

$

(10,262

)

 

 

21.0

 

%

State tax, net of federal benefit

 

 

 

 

 

 

 

Tax credits

 

 

(1,195

)

 

 

2.5

 

 

Change in valuation allowance

 

 

9,972

 

 

 

(20.4

)

 

Nontaxable or nondeductible items

 

 

 

 

 

 

 

Stock based compensation

 

 

1,081

 

 

 

(2.2

)

 

Permanent differences

 

 

56

 

 

 

(0.1

)

 

Other

 

 

(2

)

 

 

 

 

Changes in unrecognized tax benefits

 

 

359

 

 

 

(0.8

)

 

Other

 

 

3

 

 

 

 

 

Provision for income taxes

 

$

12

 

 

 

 

%

 

 

 

Year Ended December 31,

 

 

2024

 

U.S. federal taxes at statutory rate

 

 

21.0

%

State tax, net of federal benefit

 

 

8.0

 

Stock compensation

 

 

(0.7

)

Tax credits

 

 

1.5

 

Change in valuation allowance

 

 

(29.0

)

Other

 

 

(0.1

)

Total effective income tax rate

 

 

0.7

%

 

Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The types of temporary differences that give rise to significant portions of the Company’s deferred income tax assets and liabilities are set out below (in thousands):

 

 

Years Ended December 31,

 

 

2025

 

 

2024

 

Net operating loss carryforwards

 

$

14,149

 

 

$

7,122

 

Research and development credits

 

 

5,318

 

 

 

4,102

 

Operating lease liabilities

 

 

5,620

 

 

 

7,129

 

Stock-based compensation

 

 

474

 

 

 

61

 

Accrued liabilities

 

 

1,319

 

 

 

1,163

 

Section 174 capitalized research and development costs

 

 

22,932

 

 

 

20,855

 

Total deferred tax assets before valuation allowance

 

 

49,812

 

 

 

40,432

 

Valuation allowance

 

 

(44,015

)

 

 

(33,061

)

Total deferred tax assets

 

 

5,797

 

 

 

7,371

 

Property and equipment

 

 

(683

)

 

 

(766

)

Operating lease right-of-use assets

 

 

(5,114

)

 

 

(6,605

)

Total deferred tax liabilities

 

 

(5,797

)

 

 

(7,371

)

Net deferred income tax liabilities

 

$

 

 

$

 

 

The Company has established a valuation allowance for the amount of deferred tax assets that are not more likely than not to be realized. Management considered all available evidence, both positive and negative, including but not limited to the Company’s historical operating results, income or loss in recent periods, cumulative losses in recent years, forecasted earnings, future taxable income, and significant risk and uncertainty related to forecasts, and concluded the deferred tax assets are not more likely than not to be realized. The net change in the total valuation allowance for the years ended December 31, 2025 and 2024 was an increase of $11.0 million and $20.9 million, respectively.

As of December 31, 2025, the Company had $45.8 million of federal net operating loss carryforwards and $77.9 million of state net operating loss carryforwards, available to reduce future taxable income. The federal net operating loss carryforwards will carryforward indefinitely. The state net operating loss carryforwards will begin to expire in 2041, if not utilized.

As of December 31, 2025, the Company had federal research and development tax credits carryforward of $5.2 million and state research and development tax credits carryforward of $3.7 million, available to reduce future income taxes. The federal research and development tax credits will begin to expire in 2040 if not utilized. The state research and development tax credits have no expiration date.

Internal Revenue Code section 382 (“IRC Section 382”) places a limitation (the “Section 382 Limitation”) on the amount of taxable income that can be offset by net operating loss (“NOL”) carryforwards after a change in control (generally greater than 50% change in ownership) of a loss corporation. California has similar rules. When an ownership change occurs, IRC Section 382 limits the use of NOLs and credits in subsequent periods based on the annual 382 limitations. The annual 382 limitations may limit the full use of available tax attributes in one year but the identified ownership changes may not result in expiration of tax attributes for use prior to expiration of their respective carryforward periods. The Company performed a Section 382 analysis through the year ended December 31, 2024 and determined there were ownership changes in 2021 and 2023. The ownership changes did not result in a reduction of its net operating loss or in its research and development credit carryforwards expiring unused.

A reconciliation of the beginning and ending unrecognized tax benefit amount is as follows (in thousands):

 

 

Years Ended December 31,

 

 

2025

 

 

2024

 

Balance at the beginning of the year

 

$

3,567

 

 

$

2,529

 

Additions based on tax positions related to current year

 

 

620

 

 

 

998

 

Adjustment based on tax positions related to prior years

 

 

(42

)

 

 

40

 

Balance at end of the year

 

$

4,145

 

 

$

3,567

 

 

The reversal of the uncertain tax benefits would not impact the Company’s effective tax rate as the Company continues to maintain a full valuation allowance against its deferred tax assets.

The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. During the years ended December 31, 2025 and 2024, the Company did not recognize accrued interest and penalties related to unrecognized tax benefits.

The Company files income taxes in the U.S. federal jurisdiction, the state of California and various other U.S. states. The Company is not currently under examination by income tax authorities in federal, state or other jurisdictions. All income tax returns will remain open for examination by the federal, state and foreign authorities for three or four years, from the date of utilization of any NOLs or credits.

Historical Timeline

Fiscal YearFiled
2025Mar 9, 2026Showing above
2024Mar 27, 2025

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.